Author Archive

“The ICER Myth” Questions One-Size-Fits-All Approach to Drug Valuation

What is innovative medicine worth to patients?  It depends on which patient you ask.  The disease a patient suffers from, its symptoms and their impact

Read More

What Your Pharmacist Can’t Tell You

Patients overpay for their prescriptions 23 percent of the time, a recently released study from the University of Southern California found.  What’s worse – some

Read More

Mapping Report Reveals Access Disparities among European Patients

How accessible is your health care?  It all depends upon where you live, as a new report from the European Federation of Crohn’s & Ulcerative

Read More

The FDA Invitation that Patient Advocates are Awaiting

Open dialogue is an important part of the drug approval process. Physicians, patients and advocates want transparent discussion about new therapies — their benefits, their

Read More

ICER Report Dampens Prospects for Cystic Fibrosis Treatment

If health plans heed a new report from the Institute for Clinical and Economic Review, patients with few options to treat their cystic fibrosis may

Read More

What Medicare’s Opioid Policy Left Out

More than 1,000 people per day receive treatment in emergency rooms across the country for misusing prescription opioids. And approximately 115 Americans die daily from

Read More

Do You Know the Face of Someone with Essential Tremor?

By Tammy Dodderidge,  International Essential Tremor Foundation Is she nervous? Is she cold? Maybe she drank too much coffee. Could she be going through withdrawal?

Read More

***PRESS RELEASE*** Alabama Health Plans Reject More Than a Third of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More

***PRESS RELEASE*** New York Health Plans Reject Nearly a Third of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More

***PRESS RELEASE*** Some Mississippi Health Plans Reject Over 90 Percent of Claims for High Cholesterol Treatment

Health plan report card analyzes 2017 PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The non-profit Institute for Patient Access released a new Health Plan Coverage

Read More
Back to Top